The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Angiotensin II for the Treatment of Vasodilatory Shock
Open accessAbstract
BACKGROUND: Vasodilatory shock that does not respond to high-dose vasopressors is associated with high mortality. We investigated the effectiveness of angiotensin II for the treatment of patients with this condition. METHODS: We randomly assigned patients with vasodilatory shock who were receiving more than 0.2 μg of norepinephrine per kilogram of body weight per minute or the equivalent dose of another vasopressor to receive infusions of either angiotensin II or placebo. The primary end point was a response with respect to mean arterial pressure at hour 3 after the start of infusion, with response defined as an increase from baseline of at least 10 mm Hg or an increase to at least 75 mm Hg, without an increase in the dose of background vasopressors. RESULTS: A total of 344 patients were assigned to one of the two regimens; 321 received a study intervention (163 received angiotensin II, and 158 received placebo) and were included in the analysis. The primary end point was reached by more patients in the angiotensin II group (114 of 163 patients, 69.9%) than in the placebo group (37 of 158 patients, 23.4%) (odds ratio, 7.95; 95% confidence interval [CI], 4.76 to 13.3; P<0.001). At 48 hours, the mean improvement in the cardiovascular Sequential Organ Failure Assessment (SOFA) score (scores range from 0 to 4, with higher scores indicating more severe dysfunction) was greater in the angiotensin II group than in the placebo group (-1.75 vs. -1.28, P=0.01). Serious adverse events were reported in 60.7% of the patients in the angiotensin II group and in 67.1% in the placebo group. Death by day 28 occurred in 75 of 163 patients (46%) in the angiotensin II group and in 85 of 158 patients (54%) in the placebo group (hazard ratio, 0.78; 95% CI, 0.57 to 1.07; P=0.12). CONCLUSIONS: Angiotensin II effectively increased blood pressure in patients with vasodilatory shock that did not respond to high doses of conventional vasopressors. (Funded by La Jolla Pharmaceutical Company; ATHOS-3 ClinicalTrials.gov number, NCT02338843 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“There are data from RCTs in specific conditions such as pneumonia (286-289), urinary tract infections (290), bacteremia (291, 292), and intraabdominal infections (293).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [291]
Experimental — accuracy not yet measuredIn the citing paper
“The primary endpoint, an increase of MAP of at least 10 mmHg or to at least 75 mmHg, was achieved in 114 of 163 patients in the angiotensin II group and in 37 of 158 patients in the placebo group (69.9% vs 23.4%, p < 0.001).”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [366]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 15,518
APACHE II-A Severity of Disease Classification System
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,379
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,371
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940
Mayr, F., Yende, S. P., & Angus, D. C. (2013) · Virulence · doi:10.4161/viru.27372 · Cited by 1,298
López, A., Lorente, J. A., Steingrub, J. S., Bakker, J., McLuckie, A., Willatts, S. M., Brockway, M., Anzueto, A., Holzapfel, L., Breen, D. P., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000105581.01815.c6 · Cited by 917
Morelli, A., Ertmer, C., Westphal, M., Rehberg, S. W., Kampmeier, T., Ligges, S., Orecchioni, A., D’Egidio, A., D''Ippoliti, F., Raffone, C., et al. (2013) · JAMA · doi:10.1001/jama.2013.278477 · Cited by 739
History about the discovery of the renin-angiotensin system.
Basso, N., & Terragno, N. (2001) · HYPERTENSION · doi:10.1161/hy1201.101214 · Cited by 236
Survival After Shock Requiring High-Dose Vasopressor Therapy
Brown, S. M., Lanspa, M. J., Jones, J. P., Kuttler, K. G., Li, Y., Carlson, R., Miller, R. R., Hirshberg, E. L., Grissom, C. K., & Morris, A. H. (2013) · CHEST Journal · doi:10.1378/chest.12-1106 · Cited by 211
Flagged first, then by citations
Research works printed but not linked: 2
- Chawla LS, 2017, Crit Care Resusc, 19, 43
- Bassi E, 2013, Crit Care Res Pract, 2013, 654708
Cited by
Sorted by citations
Items 301–400 of 916
A time‐sensitive analysis of the prognostic utility of vasopressor dose in septic shock
Chotalia, M., Matthews, T., Arunkumar, S., Bangash, M. N., Parekh, D., & Patel, J. (2021) · Anaesthesia · doi:10.1111/anae.15453 · Cited by 15
Angiotensin-II and Thromboembolic Events: A Systematic Review*
Caragata, R., Johnston, S., Chan, J. W., Starkey, G., & Bellomo, R. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006433 · Cited by 15
Self-citationCritical Care of Patients After Pulmonary Thromboendarterectomy
Kratzert, W. B., Boyd, E., Saggar, R., & Channick, R. N. (2019) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2019.03.005 · Cited by 15
Yaribeygi, H., Maleki, M., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117916 · Cited by 15
Running, K., Weinberg, D. L., Trudo, W., Sullivan, C. L., & Patel, G. P. (2021) · A&A Practice · doi:10.1213/xaa.0000000000001402 · Cited by 15
Gulati, A., Jain, D., Agrawal, N. R., Rahate, P. V., Choudhuri, R., Das, S., Dhibar, D. P., Prabhu, M., Haveri, S., Agarwal, R., et al. (2021) · Advances in Therapy · doi:10.1007/s12325-021-01760-4 · Cited by 15
Recent advances in the pharmacological management of sepsis-associated acute kidney injury
Kalantari, K., & Rosner, M. H. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1978287 · Cited by 15
Annoni, F., Moro, F., Caruso, E., Zoerle, T., Taccone, F. S., & Zanier, E. R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.841692 · Cited by 15
Subphenotypes of acute kidney injury in children
Gist, K. M., Fuhrman, D. Y., Stanski, N. L., Menon, S., & Soranno, D. E. (2022) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000986 · Cited by 16
The medical treatment of cardiogenic shock
Lescroart, M., Péquignot, B., Janah, D., & Lévy, B. (2023) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2022.12.001 · Cited by 15
Perceptions regarding vasopressin use and practices in septic shock, and cost containment strategies
Hammond, D. A., Rech, M. A., Daley, M. J., Devlin, J. W., Hodge, E. K., Kooda, K. J., Lat, I., Personett, H. A., Roberts, R. J., Sacha, G. L., et al. (2019) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1079 · Cited by 15
Vasoactive Agents for Adult Septic Shock: An Update and Review
Dalimonte, M. A., DeGrado, J. R., & Anger, K. E. (2019) · Journal of Pharmacy Practice · doi:10.1177/0897190019844124 · Cited by 15
Angiotensin II Brings More Questions Than Answers.
Farina, N., Bixby, A. L., & Alaniz, C. (2018) · Europe PMC (PubMed Central) · Cited by 15
Use of vasopressors during esophagectomy is not associated with increased risk of anastomotic leak
Walsh, K. J., Zhang, H., Tan, K. S., Pedoto, A. C., Desiderio, D. P., Fischer, G. W., Bains, M. S., Jones, D. R., Molena, D., & Amar, D. (2020) · Diseases of the Esophagus · doi:10.1093/dote/doaa090 · Cited by 15
The Role of Angiotensin II in Poisoning-Induced Shock—a Review
Chen, A., & Wong, A. (2022) · Journal of Medical Toxicology · doi:10.1007/s13181-022-00885-4 · Cited by 14
Priyanka, P., Chang, C.-C. H., Chawla, L. S., Kellum, J. A., Clermont, G., & Murugan, R. (2022) · Shock · doi:10.1097/shk.0000000000001980 · Cited by 14
Self-citationThe Eight Unanswered and Answered Questions about the Use of Vasopressors in Septic Shock
Hamzaoui, O., Goury, A., & Teboul, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144589 · Cited by 14
Wayland, J., Teixeira, J. P., & Nielsen, N. D. (2024) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2024.06.010 · Cited by 16
Marmiere, M., D’Amico, F., Monti, G., & Landoni, G. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006532 · Cited by 14
Early high-dose vasopressors in refractory septic shock: A cohort study
Thompson, H. A., Brinkman, H. M., KASHANI, K. B., Mara, K. C., Wittwer, E. D., & Wieruszewski, P. M. (2024) · Journal of Critical Care · doi:10.1016/j.jcrc.2024.155004 · Cited by 14
Melchers, M., de Smet, V., Rooijakkers, C., Huising, J., Vermeulen, W., Köktaş, B. N. N., van de Vusse, K. J., Sabzewar, K. M., Mishra, S. B., Bethlehem, C., et al. (2025) · Annals of Intensive Care · doi:10.1186/s13613-025-01472-w · Cited by 14
Pirracchio, R., Fong, N., & Legrand, M. M. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-08104-8 · Cited by 14
Panwar, R. (2017) · Shock · doi:10.1097/shk.0000000000001033 · Cited by 14
Self-citationUpdates in Sepsis Resuscitation
Ellender, T. J., & Benzoni, N. S. (2020) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2020.06.006 · Cited by 14
Schenck, E. J., Hoffman, K. L., Oromendia, C., Sánchez, E., Finkelsztein, E. J., Hong, K. S., Kabariti, J., Torres, L. K., Harrington, J. S., Siempos, I. Ι., et al. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202004-399oc · Cited by 14
Jha, A., Zilahi, G., & Rhodes, A. (2021) · BJA Education · doi:10.1016/j.bjae.2021.03.002 · Cited by 14
Precision fluid and vasoactive drug therapy for critically ill patients
Bauer, S. R., Gellatly, R. M., & Erstad, B. L. (2023) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2763 · Cited by 15
Sepsis-Associated Acute Kidney Injury
Wang, D., Sun, T., & Liu, Z. (2023) · Intensive Care Research · doi:10.1007/s44231-023-00049-0 · Cited by 17
Addison, M., Ranasinghe, P. D., & Webb, D. J. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2277330 · Cited by 14
Angiotensin II (Giapreza): A Distinct Mechanism for the Treatment of Vasodilatory Shock
Khalique, S. C., & Ferguson, N. (2018) · Cardiology in Review · doi:10.1097/crd.0000000000000247 · Cited by 14
Septic acute kidney injury: a review of basic research
Nakano, D. (2020) · Clinical and Experimental Nephrology · doi:10.1007/s10157-020-01951-3 · Cited by 14
Successful use of angiotensin II for vasoplegia after thoracoabdominal aortic aneurysm repair
Chatterjee, S., Preventza, O. A., Mousavi, M., Orozco‐Sevilla, V., LeMaire, S. A., & Coselli, J. S. (2020) · JTCVS Techniques · doi:10.1016/j.xjtc.2020.08.007 · Cited by 14
Léone, M., Myatra, S. N., Dugar, S. P., Wieruszewski, P. M., Russell, L., Evans, L., Delamarre, L., Sharif, S., Chew, M. S., Gong, M. N., et al. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08344-2 · Cited by 13
Self-citationTeixeira, J. P., Inglés, D. P., Barton, J., Dean, J. T., García, P., Kunkel, S. J., Sarangarm, P., Weiss, N. K., Schaich, C. L., Busse, L. W., et al. (2024) · Trials · doi:10.1186/s13063-024-07995-0 · Cited by 13
Self-citationWhite, K. C., Laupland, K. B., Ostermann, M., Neto, A. S., Gatton, M. L., Hurford, R., Clement, P., Sanderson, B., & Bellomo, R. (2024) · Blood Purification · doi:10.1159/000538421 · Cited by 13
Self-citationCadd, M., Watson, U., Kilpatrick, T., Hardy, B., Gallop, L., Gerard, A., & Cabaret, C. (2024) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2024.09.135 · Cited by 13
Microcirculation-guided protection strategy in hemodynamic therapy
Pan, P., Su, L., Liu, D., & Wang, X. (2020) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-190784 · Cited by 13
Self-citationManejo perioperatorio en cirugía cardiovascular
Rivera, J. J. J., Jorge, C. L., Gude, M. J. L., & Vela, J. L. P. (2020) · Medicina Intensiva · doi:10.1016/j.medin.2020.10.006 · Cited by 13
Defining Vasoplegia Following Durable, Continuous Flow Left Ventricular Assist Device Implantation
Swan, J. T., Iso, T., Rizk, E., Trachtenberg, B. H., Krisl, J. C., Varnado, S., Suki, W. N., Frost, A. E., Suarez, E. E., Uddin, F. S., et al. (2021) · ASAIO Journal · doi:10.1097/mat.0000000000001419 · Cited by 13
Bird, S., Chand, M., Tran, T. L., Ali, S., Awad, S. S., Cornwell, L. D., Schütz, A., & Jiménez, E. (2022) · Annals of Pharmacotherapy · doi:10.1177/10600280221099928 · Cited by 13
CIRMI—a new term for a concept worthy of further exploration: a narrative review
Nethathe, G. D., Lipman, J., Anderson, R., & Feldman, C. H. (2022) · Annals of Translational Medicine · doi:10.21037/atm-21-5572 · Cited by 15
Distinct host-response signatures in circulatory shock: a narrative review
Soussi, S., dos Santos, C. C., Jentzer, J. C., Mebazaa, A., Gayat, É., Pöss, J., Schaubroeck, H., Billia, F., Marshall, J. C., & Lawler, P. R. (2023) · Intensive Care Medicine Experimental · doi:10.1186/s40635-023-00531-5 · Cited by 13
Intensive care medicine in 2050: vasopressors in sepsis
Teboul, J., Duranteau, J., & Russell, J. A. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4909-7 · Cited by 13
Abril, M. K., Khanna, A. K., Kroll, S., McNamara, C., Handisides, D. R., & Busse, L. W. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.12.007 · Cited by 13
Self-citationde Roquetaillade, C., Jamme, M., Charpentier, J., Chiche, J., Cariou, A., Mira, J. P., Pène, F., & Llitjos, J. (2020) · Shock · doi:10.1097/shk.0000000000001524 · Cited by 13
Perioperatives Flüssigkeitsmanagement bei großen viszeralchirurgischen Eingriffen
von der Forst, M., Weiterer, S., Dietrich, M., Loos, M., Lichtenstern, C., Weigand, M. A., & Siegler, B. H. (2020) · Der Anaesthesist · doi:10.1007/s00101-020-00867-7 · Cited by 13
Dysfunction of the renin-angiotensin-aldosterone system in human septic shock
Schaich, C. L., Leisman, D. E., Goldberg, M. B., Filbin, M. R., Khanna, A. K., & Chappell, M. C. (2024) · Peptides · doi:10.1016/j.peptides.2024.171201 · Cited by 12
Self-citationA Blast From the Past: Revival of Angiotensin II for Vasodilatory Shock
Bissell, B. D., Browder, K., McKenzie, M., & Flannery, A. H. (2018) · Annals of Pharmacotherapy · doi:10.1177/1060028018767899 · Cited by 12
Wu, G., Mu, T., Zhang, L., & Chen, X. (2020) · Cellular and Molecular Biology · doi:10.14715/cmb/2020.66.2.20 · Cited by 12
Vasopressin Response and Clinical Trajectory in Septic Shock Patients
Bauer, S. R., Sacha, G. L., Siuba, M., Wang, L., Wang, X., Scheraga, R. G., & Vachharajani, V. (2022) · Journal of Intensive Care Medicine · doi:10.1177/08850666221118282 · Cited by 12
Self-citationNot all Shock States Are Created Equal
Khorsand, S., Helou, M. F., Satyapriya, V., Kopanczyk, R., & Khanna, A. K. (2023) · Anesthesiology Clinics · doi:10.1016/j.anclin.2022.11.002 · Cited by 14
Self-citationThe use of angiotensin II for the management of distributive shock: expert consensus statements
Landoni, G., Cortegiani, A., Bignami, E., PASCALE, G. D., Donadello, K., Donati, A., Grasselli, G., Guarracino, F., Monti, G., Paternoster, G., et al. (2024) · Journal of Anesthesia Analgesia and Critical Care · doi:10.1186/s44158-024-00186-y · Cited by 12
Use of diuretics in shock: Temporal trends and clinical impacts in a propensity-matched cohort study
Bandak, G. S. I., Sakhuja, A., Andrijasevic, N. M., Gunderson, T. M., Gajic, O., & KASHANI, K. B. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228274 · Cited by 12
Trethowan, B., Michaud, C. J., & Fifer, S. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004502 · Cited by 12
New drugs for acute kidney injury
Côté, J., Murray, P. T., & Rosner, M. H. (2020) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000778 · Cited by 12
Larivière, J., Giard, J., Zuo, R. M., Massicotte, L., Chassé, M., & Carrier, F. M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254455 · Cited by 12
50 Years of Sepsis Investigation/Enlightenment Among Adults—The Long and Winding Road
Dellinger, R. P., Levy, M. M., Schorr, C., & Townsend, S. R. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005203 · Cited by 12
Mohamed, A., Berry, T. P., Welge, J. A., Thomas, E. L., Zhurav, L., Kozinn, J. B., & Haines, M. M. (2022) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2022.01.002 · Cited by 12
Review article: Sepsis in the emergency department – Part 3: Treatment
Williams, J. M., Keijzers, G., Macdonald, S. P. J., Shetty, A., & Fraser, J. F. (2018) · Emergency Medicine Australasia · doi:10.1111/1742-6723.12951 · Cited by 12
Hong, A. W., Toppen, W., Lee, J., Wilhalme, H. M., Saggar, R., & Barjaktarević, I. (2022) · Journal of Intensive Care Medicine · doi:10.1177/08850666221118839 · Cited by 11
Wang, L., Zhang, T., Yao, H., Xu, Q., Fu, X., Yang, J., Wang, B., Zhang, Z., Jin, X., Kang, Y., et al. (2022) · Nutrients · doi:10.3390/nu14245393 · Cited by 13
Hwang, K. Y., Phoon, P. H. Y., & Hwang, N. C. (2023) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2023.12.016 · Cited by 11
Norepinephrine dosing in France: Time to move forward!
Goyer, I., Lakbar, I., Freund, Y., Lévy, B., & Léone, M. (2024) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2024.101397 · Cited by 11
McDonald, R., Watchorn, J. C., Mehta, R., Ostermann, M., & Hutchings, S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304227 · Cited by 11
Self-citationManagement of vasoplegic shock
Mistry, R. N., & Winearls, J. (2024) · BJA Education · doi:10.1016/j.bjae.2024.10.004 · Cited by 12
White, K. C., Bellomo, R., Laupland, K. B., Gatton, M. L., Ostermann, M., McIlroy, P., Luke, S., Garrett, P., Tabah, A., Whebell, S. F., et al. (2025) · Journal of Critical Care · doi:10.1016/j.jcrc.2025.155016 · Cited by 11
Self-citationAcute Kidney Injury During Sepsis and Prognostic Role of Coexistent Chronic Heart Failure
Soukup, J., & Pliquett, R. U. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14030964 · Cited by 11
Chow, J. H., Wallis, M., Lankford, A. S., Chancer, Z., Barth, R. N., Scalea, J. R., LaMattina, J. C., Mazzeffi, M. A., & McCurdy, M. T. (2020) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/1089253220949070 · Cited by 11
Self-citationAngiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting
Sovic, W. R., Mathew, C., Blough, B. A., Monday, K., Sam, T., Zafar, H., Guerrero-Miranda, C. Y., Sherwood, M., Hebert, C., HALL, S. A., et al. (2021) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.576 · Cited by 11
Fármacos vasoactivos en el tratamiento del shock séptico
Andaluz‐Ojeda, D., Cantón‐Bulnes, M. L., Richter, C. P., & Garnacho‐Montero, J. (2022) · Medicina Intensiva · doi:10.1016/j.medin.2022.03.001 · Cited by 12
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock
Albertson, T. E., Chenoweth, J., Lewis, J., Pugashetti, J. V., Sandrock, C. E., & Morrissey, B. M. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2110067 · Cited by 11
Self-citationANGIOTENSIN II IN THE TREATMENT OF DISTRIBUTIVE SHOCK: A SYSTEMATIC-REVIEW AND META-ANALYSIS
Xourgia, E., Exadaktylos, A. K., Chalkias, A. F., & Ziaka, M. (2024) · Shock · doi:10.1097/shk.0000000000002384 · Cited by 11
Nasser, A. A., Chaba, A., Laupland, K. B., Ramanan, M., Tabah, A., Attokaran, A. G., Kumar, A., McCullough, J., Shekar, K., Garrett, P., et al. (2024) · Critical Care and Resuscitation · doi:10.1016/j.ccrj.2024.09.003 · Cited by 11
Self-citationVollmer, N. J., Wieruszewski, P. M., Martin, N. J., Seelhammer, T. G., Wittwer, E. D., Nabzdyk, C. S., Mara, K. C., & Nei, S. D. (2022) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2022.01.021 · Cited by 11
A current appraisal of evidence for the approach to sepsis and septic shock
Varon, J., & Baron, R. M. (2019) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936119856517 · Cited by 11
Angiotensin II for the Treatment of Vasodilatory Shock — Promise and Caution
Dellinger, R. P., & Trzeciak, S. (2017) · New England Journal of Medicine · doi:10.1056/nejme1706903 · Cited by 11
The evolving role of the renin–angiotensin system in ARDS
Vrigκou, E., Tsangaris, I., Bonovas, S., Tsantes, A., & Kopterides, P. (2017) · Critical Care · doi:10.1186/s13054-017-1917-5 · Cited by 11
Kanjo, A., Molnár, Z., Zádori, N., Gede, N., Erőss, B. M., Szakó, L., Kiss, T., Márton, Z., Malbrain, M. L. N. G., Szuldrzynski, K. S., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050464 · Cited by 10
Kotani, Y., Ursoleo, J. D., Murru, C. P., & Landoni, G. (2024) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2024.04.010 · Cited by 10
The U.S. FDA approved cardiovascular drugs from 2011 to 2023: A medicinal chemistry perspective
Jiang, Y., Liu, P., Qiu, Z., Zhou, M., Cheng, M., & Yang, T. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116593 · Cited by 10
Luis-Silva, F., Menegüeti, M. G., Peres, L. M., Sepeda, C. D. R., Jordani, M. C., Mestriner, F., Petroski-Moraes, B. C., Brito‐de‐Sousa, J. P., da Costa-Rocha, I. A., Cruz, B. L., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1431321 · Cited by 10
Chaba, A., Zarbock, A., Forni, L. G., Hästbacka, J., Korneva, E., Landoni, G., Pickkers, P., & Bellomo, R. (2024) · Shock · doi:10.1097/shk.0000000000002481 · Cited by 10
Self-citationKotani, Y., Lezzi, M., Murru, C. P., Khanna, A. K., Zarbock, A., Bellomo, R., & Landoni, G. (2024) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2024.12.022 · Cited by 10
Self-citationProgression of Kidney Fibrosis after Sepsis
de Roquetaillade, C., Durand, M., Beaucoté, V., Guillemin, J., Chadjichristos, C. E., Roquilly, A., & Chousterman, B. G. (2025) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000712 · Cited by 10
Wang, H., Das, S., Wieruszewski, P. M., Taji, J., Bartlett, B. N., Azad, N., Chowdhury, A., Kolar, G. J., Jain, N. K., Subla, M. R., et al. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.04.015 · Cited by 10
Roles of Angiotensin II as Vasopressor in Vasodilatory Shock
Lumlertgul, N., & Ostermann, M. (2020) · Future Cardiology · doi:10.2217/fca-2020-0019 · Cited by 10
Self-citationHemodynamic Effects of an Increased Midodrine Dosing Frequency
Macielak, S. A., Vollmer, N. J., Haddad, N. A., Nabzdyk, C. S., & Nei, S. D. (2021) · Critical Care Explorations · doi:10.1097/cce.0000000000000405 · Cited by 10
Dixon, W., Sheetz, K. H., Adelmann, D., Bokoch, M. P., Reddy, M., Kothari, R. P., Roberts, J. P., Syed, S. M., Feng, S., & Roll, G. R. (2023) · Clinical Transplantation · doi:10.1111/ctr.15049 · Cited by 10
Angiotensin II for the Treatment of Refractory Shock: A Matched Analysis*
Smith, L. M., Mentz, G. B., & Engoren, M. (2023) · Critical Care Medicine · doi:10.1097/ccm.0000000000005975 · Cited by 10
Mottling in Septic Shock: Ethnicity and Skin Color Matter
Jog, S., Vikram, L., Rajhans, P., Akole, P., Pawar, B., Bhurke, B., Mahale, N., Chavan, S., Dalvi, P., Marudwar, P., et al. (2023) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24586 · Cited by 10
Impact of Recent Clinical Trials on Nephrology Practice: Are We in a Stagnant Era?
Yaseen, M., Hassan, W., Awad, R., Ashqar, B., Neyra, J. A., Heister, T., Malik, O., & El-Husseini, A. A. (2018) · Kidney Diseases · doi:10.1159/000495139 · Cited by 11
Successful Treatment of Antihypertensive Overdose Using Intravenous Angiotensin II
Carpenter, J. E., Murray, B. P., Saghafi, R., Thomas, B., Lee, S., Kleiman, R., Punja, M., Silver, E., & Busse, L. W. (2019) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2019.05.027 · Cited by 10
Self-citationWentowski, C. C., Inglés, D. P., & Nielsen, N. D. (2021) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2021.10.001 · Cited by 11
Angiotensin II - A Brief Review and Role in Severe SARS-COV-2 Sepsis
Carà, G. A., Pasin, L., Alborino, E., Zarbock, A., Bellomo, R., & Landoni, G. (2022) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2022.07.022 · Cited by 10
Self-citationMethylene Blue Does Not Improve Vasoplegia After Left Ventricular Assist Device Implantation
Saha, A., Jennings, D. L., Ning, Y., Kurlansky, P. A., Miltiades, A., Spellman, J. L., Sanchez, J. E., yuzefpolskaya, M., Colombo, P. C., Takayama, H., et al. (2020) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2020.05.172 · Cited by 10
Vasoplegia from Continuous Flow Left Ventricular Assist Devices
Sathianathan, S., Bhat, G., & Dowling, R. D. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01534-y · Cited by 9
Emerging concepts in the care of patients with cirrhosis and septic shock
Jiménez, J. V., García–Tsao, G., & Saffo, S. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i4.497 · Cited by 9
Should we initiate vasopressors earlier in patients with septic shock: A mini systemic review
Zhou, H.-X., Yang, C.-F., Wang, H.-Y., Teng, Y., & He, H. (2023) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v12.i4.204 · Cited by 9
Antonucci, E., Garcia, B., & Legrand, M. M. (2024) · Anesthesiology · doi:10.1097/aln.0000000000004958 · Cited by 12
White, K. C., Bellomo, R., Tabah, A., Attokaran, A. G., White, H., McCullough, J., Shekar, K., Ramanan, M., Garrett, P., McIlroy, P., et al. (2024) · Nephrology · doi:10.1111/nep.14392 · Cited by 9
Self-citation
Metadata
- Authors
- Khanna, A., English, S. W., Wang, X. S., Ham, K., Tumlin, J., Szerlip, H., Busse, L. W., Altaweel, L., Albertson, T. E., Mackey, C., McCurdy, M. T., Boldt, D. W., Chock, S., Young, P. J., Krell, K., Wunderink, R. G., Ostermann, M., Murugan, R., Gong, M. N., Panwar, R., Hästbacka, J., Favory, R., Venkatesh, B., Thompson, B. T., Bellomo, R., Jensen, J., Kroll, S., Chawla, L. S., Tidmarsh, G. F., & Deane, A. M.
- Affiliations
- Cleveland Clinic (US)
- Regions Hospital (US)
- Inova Health System (US)
- Albert Einstein College of Medicine (US)
- University of Maryland, Baltimore (US)
- Northwestern University (US)
- ORCID
- Khanna, Ashish
- English, Shane W.
- Ham, Kealy
- Szerlip, Harold
- Busse, Laurence W.
- Albertson, Timothy E.
- McCurdy, Michael T.
- Young, Paul J.
- Wunderink, Richard G.
- Ostermann, Marlies
- Murugan, Raghavan
- Gong, Michelle N.
- Panwar, Rakshit
- Hästbacka, Johanna
- Venkatesh, Balasubramanian
- Thompson, B. Taylor
- Bellomo, Rinaldo
- Chawla, Lakhmir S.
- Deane, Adam M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-08-03
- Volume
- 377
- Issue
- 5
- Pages
- 419-430
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2614578436
- Cited by
- 916
- References
- 24
- Citations by year
- 2026: 100 · 2025: 103 · 2024: 121 · 2023: 103 · 2022: 90 · 2021: 95 · 2020: 123 · 2019: 80 · 2018: 75 · 2017: 25
- FWCI
- 64.87
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Figshare (submittedVersion)
- Työväentutkimus Vuosikirja (submittedVersion)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
- NOVA (University of Newcastle Australia) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- GlaxoSmithKline
- La Jolla Pharmaceutical Company
- Alexion Pharmaceuticals
- Regeneron Pharmaceuticals
- Genentech
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
- Keywords
- angiotensin II, vasodilatory shock, septic shock, vasopressors, norepinephrine, mean arterial pressure, SOFA score, mortality, blood pressure response, adverse events, sepsis treatment, vasopressor-refractory shock, fluid resuscitation, vasopressor dose reduction, organ dysfunction, 28-day mortality
- MeSH terms
- Aged, Angiotensin II, Blood Pressure, Catecholamines, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Hypotension, Male, Middle Aged, Shock, Vasoconstrictor Agents, Organ Dysfunction Scores
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
